Try our Advanced Search for more refined results
Mylan Pharmaceuticals Inc v. Sanofi-Aventis Deutschland GmbH
Case Number:
Case Type:
IPR
Status:
Final Written Decision
Petitioner:
Mylan Pharmaceuticals Inc
Patent Owner:
Sanofi-Aventis Deutschland GmbH
Tech Center:
3700
-
May 29, 2020
Mylan Gets More Sanofi Insulin Pen Patents Nixed At PTAB
Generic-drug maker Mylan convinced the Patent Trial and Appeal Board to nix a handful of Sanofi-Aventis patents Friday covering the Lantus SoloStar disposable insulin injection pen, adding to its past wins in cases related to the same product.
-
February 05, 2020
Mylan Says Amendment Feedback Doesn't Save Sanofi IP
Mylan urged the Patent Trial and Appeal Board on Wednesday to reject Sanofi-Aventis' substitute claims to insulin pen patents that were the first to pass through a new program that provides early feedback on proposed amendments.
-
October 18, 2019
PTAB Gives Sanofi First-Ever Early Feedback On Amendments
Sanofi's proposed adjustments to insulin patents being challenged by Mylan likely won't pass muster, the Patent Trial and Appeal Board has said in its first-ever guidance under a new program that provides early feedback on proposed amendments.